Article
Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis
11 Aug 2017
Abstract excerpt
INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive degenerative motor neuron disease, which usually leads to death within a few years. The diagnosis is mainly based on clinical symptoms and there is a need for ALS-specific biomarkers to make an early and precise diagnosis, for development of disease-modifying drugs and to gain new insights into pathophysiology. Areas covered: In the present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
